MiNK Therapeutics Statistics
Total Valuation
INKT has a market cap or net worth of $28.08 million. The enterprise value is $23.17 million.
Important Dates
The next estimated earnings date is Thursday, November 7, 2024, before market open.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
INKT has 39.54 million shares outstanding. The number of shares has increased by 3.60% in one year.
Shares Outstanding | 39.54M |
Shares Change (YoY) | +3.60% |
Shares Change (QoQ) | +7.21% |
Owned by Insiders (%) | 19.42% |
Owned by Institutions (%) | 2.28% |
Float | 10.09M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.93
Current Ratio | 0.93 |
Quick Ratio | 0.92 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -97.25% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$551,289 |
Employee Count | 31 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.31% in the last 52 weeks. The beta is 0.05, so INKT's price volatility has been lower than the market average.
Beta (5Y) | 0.05 |
52-Week Price Change | -39.31% |
50-Day Moving Average | 0.80 |
200-Day Moving Average | 0.92 |
Relative Strength Index (RSI) | 33.62 |
Average Volume (20 Days) | 17,421 |
Short Selling Information
The latest short interest is 62,008, so 0.16% of the outstanding shares have been sold short.
Short Interest | 62,008 |
Short Previous Month | 50,622 |
Short % of Shares Out | 0.16% |
Short % of Float | 0.61% |
Short Ratio (days to cover) | 2.18 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -17.46M |
Pretax Income | -20.59M |
Net Income | -17.09M |
EBITDA | -17.25M |
EBIT | -17.46M |
Earnings Per Share (EPS) | -$0.49 |
Full Income Statement Balance Sheet
The company has $9.31 million in cash and $4.41 million in debt, giving a net cash position of $4.91 million or $0.12 per share.
Cash & Cash Equivalents | 9.31M |
Total Debt | 4.41M |
Net Cash | 4.91M |
Net Cash Per Share | $0.12 |
Equity (Book Value) | -16.58M |
Book Value Per Share | -0.42 |
Working Capital | -673,718 |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$12.08 million and capital expenditures -$23,043, giving a free cash flow of -$12.10 million.
Operating Cash Flow | -12.08M |
Capital Expenditures | -23,043 |
Free Cash Flow | -12.10M |
FCF Per Share | -$0.31 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |